Spinal device developer Baxano raises $20M
Baxano, a startup in stealth mode that’s developing a spinal medical device, has raised $20 million in a second round of funding, according to VentureWire. The round was led by new backer Kearny Venture Partners, with participation from existing investors Prospect Venture Partners and Three Arch Partners.
Mountain View, Calif.-based Baxano raised an $8.6 million first round in Deember 2006. Chief executive Jeffrey Bleich says his company’s device will be less invasive and more effective than… Continue Reading
Life-science briefing: Monday, March 31, 2008
TODAY’S HEADLINES:
Boston Scientific spinout TriVascular2 takes in $65M (release)
Inhaled-drug startup Transave raises $35M (release)
Triage Wireless gets $20M for vital-signs monitors (release)
Tryton Medical receives $14M for “bifurcation” stents (release)
Synthetic bio startup Codon Devices adds $11M (release)
Tracon Pharma takes in $4.5M against cancer and eye disease (VentureWire)
Antibody maker f-star swaps in equity stake by TVM (PDF release)
Drug packager MonoSol Rx withdraws IPO (IPOhome)
GE Healthcare acquires portable-ventilator maker VersaMed (release)
Boston Scientific spinout TriVascular2 takes in $65M – In 2005, Boston… Continue Reading
Life sciences briefing: Tuesday, Jan. 22, 2007
TODAY’S HEADLINES:
Teva acquires protein-therapeutic maker CoGenesys for $400M (release)
ViewRay takes in $25M for MRI radiation-therapy guidance (release)
NovaMed, Chinese clinical-research outfit, receives $14M (release)
Progentix Ortho raises first funding round (release)
Medical imaging co. Point Biomedical recaps with $25M (VentureWire)
Lumidigm takes in $7M for optical-fingerprint ID systems (VW)
Medical-software co. Compressus aims to close $14M round (VW)
Channel Medical Partners aims for $150M med-tech fund (VW)
Spinal-implant maker Scient’x names Michael Huggins as CEO (release)
Specialty pharma Cardiokine names Manuel Worcel as… Continue Reading
Kearny Venture Partners raises $85M of planned $180M fund for healthcare
Kearny Venture Partners, a healthcare focused venture capital firm in San Francisco, has raised an initial $85 million for its latest fund.
The news was first reported by PE Week last week, and followed today by VentureWire (sub required) with a longer story. News comes in dribbles because firms like Kearny tend to raise their funds in portions.
Kearny was formed by a team from Thomas Weisel Healthcare Venture Partners, and had planned to raise $150… Continue Reading